STI
31
19
INTC
49
16
RCL
88
-2
NSC
64
2
GOOG
69
-10
UNH
63
-2
WHR
70
4
PWR
71
-3
SCHW
65
-2
PSA
58
5
PX
73
-6
WMB
68
-2
SE
60
-5
GPC
40
2
STZ
58
3
XOM
51
3
QRVO
4
-2
DLTR
40
4
FRT
48
2
URBN
66
2
STI
31
19
INTC
49
16
RCL
88
-2
NSC
64
2
GOOG
69
-10
UNH
63
-2
WHR
70
4
PWR
71
-3
SCHW
65
-2
PSA
58
5
PX
73
-6
WMB
68
-2
SE
60
-5
GPC
40
2
STZ
58
3
XOM
51
3
QRVO
4
-2
DLTR
40
4
FRT
48
2
URBN
66
2
Financhill
Back

Morningstar 10K Form

Buy
63

MORN
Morningstar

Last Price:
342.72
Seasonality Move:
2.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MORN News And Ratings

See the #1 stock for the next 7 days that we like better than MORN

MORN Financial Statistics

Sales & Book Value

Annual Sales: $2.04B
Cash Flow: $155.8M
Price / Cash Flow: 34.06
Annual Sales: $36.51
Price / Book: 9.6

Profitability

EPS (TTM): 7.57000
Net Income (TTM): $326.5M
Gross Margin: $1.2B
Return on Equity: 23.47%
Return on Assets: 9.54%

Morningstar Earnings Forecast

Key Morningstar Financial Ratios

  • The Gross Profit Margin over the past 22 years for MORN is 58.62%.
  • The Selling, General & Administrative Expenses for MORN have been equal to 38.24% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 43.02% of Operating Income.
  • The Net Earning history of MORN is 6.92% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 16 years.

Morningstar Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Capital Markets
Sector: Financials
Current Symbol: MORN
CUSIP: 617700
Website: morningstar.com

Debt

Debt-to-Equity Ratio: 0.55
Current Ratio: 1.14
Quick Ratio: 1.04

Price-to-Earnings

Trailing P/E Ratio: 106.55
Forward P/E Ratio: 38.65

MORN Technical Analysis vs Fundamental Analysis

Buy
63
Morningstar (MORN) is a Buy

Is Morningstar a Buy or a Sell?

  • Morningstar stock is rated a Buy
    The current Morningstar [MORN] share price is $345.47. The Score for MORN is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.